Pulmonx to Participate in the Piper Sandler 38th Annual Healthcare Conference
REDWOOD CITY, Calif., Nov. 18, 2026 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”) a global leader in minimally invasive treatments for severe lung disease, today announced the company will be participating in a fireside discussion at the Piper Sandler 38 th Annual Healthcare Conference in New York City on Wednesday, December 2, 2026, at 1:30 PM PT / 4:30 PM ET. The company will also be hosting in-person investor meetings.